Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-15 of 15 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Armenia | Global Fund | MYLAN LABORATORIES LTD | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.4333 | 1590 | 30 | 13 | 53 | 689 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 2 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5070 | 30 | 16.95 | 169 | 2864.55 | IDA Foundation | 2015 | Not specified | Yes | Not specified | |||
| 3 | Republic of Moldova | Global Fund | Hetero labs Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.565 | 5040 | 30 | 16.95 | 168 | 2847.6 | 2015 | Not specified | Yes | Not specified | ||||
| 4 | Kyrgyz Republic | Global Fund | Aurobindo Pharma Ltd. | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | - | 30 | 15.5 | - | - | UNDP/UNICEF | 2015 | 2014-12-31 | 2015-12-30 | Not specified | Not specified | Not specified | |
| 5 | Republic of Tajikistan | Global Fund | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.5167 | 30 | 30 | 15.5 | 1 | 15.5 | Not specified | Not specified | Not specified | |||||
| 6 | Ukraine | Global Fund | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.02 | 30 | 30 | 30.6 | 1 | 30.6 | 2015 | Not specified | Not specified | Not specified | ||||
| 7 | Russian Federation | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 4.002 | 4361970 | 30 | 120.06 | 145399 | 17456604 | 2015 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Kazakhstan | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.3777 | 3047400 | 30 | 11.33 | 101580 | 1150901.38 | 2015 | Not specified | Not specified | Not specified | |||
| 9 | Republic of Lithuania | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.1373 | 30 | 30 | 334.12 | 1 | 334.12 | Viiv Healthcare UK Limited | Not specified | Yes | Not specified | |||
| 10 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 66000 | 30 | 425 | 2200 | 935000 | Not specified | Not specified | Not specified | ||||
| 11 | Republic of Poland | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 195000 | 30 | 425 | 6500 | 2762500 | Not specified | Not specified | Not specified | ||||
| 12 | Republic of Poland | Government | Viiv Healthcare UK Limited | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 14.1667 | 18000 | 30 | 425 | 600 | 255000 | Not specified | Not specified | Not specified | ||||
| 13 | Republic of Latvia | Government | ViiV Healthcare | Kivexa | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 11.619 | 30 | 30 | 348.57 | 1 | 348.57 | Not specified | Not specified | Not specified | ||||
| 14 | Ukraine | Government | GlaxoSmithKline | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 0.9797 | 171930 | 30 | 29.39 | 5731 | 168434.09 | 2016 | Not specified | Not specified | Not specified | ||||
| 15 | Republiс of Azerbaijan | Government | ViiV Healthcare | Abacavir+Lamivudine - FDC | 600mg+300mg tab | 1.7167 | 21960 | 30 | 51.5 | 732 | 37698 | Yes | Yes | Not specified |